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ThermodynamicMelittin is an amphipathic peptidewhich has receivedmuchattention as amodel peptide for peptide–membrane
interactions. It is however not suited as a transfection agent due to its cytolytic and toxicological effects. Retro-
inverso-melittin, when covalently linked to the lipid 1,2-dioleoyl-sn-glycero-3-phosphoethanolamine (riDOM),
eliminates these shortcomings. The interaction of riDOM with phospholipid membranes was investigated with
circular dichroism (CD) spectroscopy, dynamic light scattering, ζ-potential measurements, and high-sensitivity
isothermal titration calorimetry. riDOM forms cationic nanoparticles with a diameter of ~13 nm which are
well soluble in water and bind with high afﬁnity to DNA and lipid membranes. When dissolved in bilayer mem-
branes, riDOMnanoparticles dissociate and form transient pores. riDOM-inducedmembrane leakiness is howev-
ermuch reduced compared to that of authenticmelittin. The secondary structure of the ri-melittin is not changed
when riDOM is transferred fromwater to themembrane and displays a large fraction of β-structure. The 31P NMR
spectrum of the nanoparticle is however transformed into a typical bilayer spectrum. The Gibbs free energy of
riDOM binding to bilayer membranes is−8.0 to−10.0 kcal/mol which corresponds to the partition energy of
just one fatty acyl chain. Half of the hydrophobic surface of the riDOM lipid extension with its 2 oleic acyl chains
is therefore involved in a lipid–peptide interaction. This packing arrangement guarantees a good solubility of
riDOM both in the aqueous and in the membrane phase. The membrane binding enthalpy is small and riDOM
binding is thus entropy-driven.
© 2013 Published by Elsevier B.V.1. Introduction
Melittin, an amphipathic peptide and the main component of
the venom of the honey bee Apis mellifera, is probably the most widely
studied membrane-interacting peptide. It possesses a net positive
charge but easily inserts into lipid membranes [1–5]. Cationic melittin
also binds to DNA with a high afﬁnity by electrostatic interactions
with the anionic phosphate backbone [6]. However the melittin/DNA
complex does not mediate transfection and the complex is toxic caused
probably by lysis of the cell membrane [7–9].
In order to reduce toxic effects and to improve both stability and
transfection efﬁciency of melittin/DNA complexes different approaches
have been used. Melittin analogs, PEI–melittin, and polylysine–melittin
conjugates have been synthesized. They mediate efﬁcient transfection,
but their lytic activity is still high [7,8,10]. Other systems such as
poly-melittin peptides and polylysine–melittin–dimethylmaleic acid
conjugates exhibit reduced toxicity of melittin and high gene expres-
sion levels [10,11].
An alternative method to create a stable and efﬁcient gene
delivery system is the conjugation of a peptide to a lipid moiety
[12–15]. Dioleoylmelittin (DOM) is one of such hybrid molecules41 61 267 2189.
batte), eric_a.kitas@roche.com
vier B.V.[13]. It has been synthesized by covalent binding of a lipid,
dioleoylphosphatidylethanolamine-N-[3-(2-pyridyldithio)propionate],
to an analog of melittin, [Cys1]melittin, in which the N-terminal glycine
is replaced by cysteine. Electron microscopy of DOM solutions using
uranyl acetate staining suggests spherical structures with diameters
between 5 and 10 nm. When DOM is added to plasmid DNA it forms
homogeneous particles with a diameter of ~170 to 250 nm depending
on the DNA/DOM ratio.
DOM is an efﬁcient transfection agent [13]. However, even though
DOM has a lower hemolytic activity than melittin, it is still toxic and
not stable. Retro-inverso dioleoylmelittin (riDOM) is identical to DOM
except that all L-amino acid residues are replaced by the corresponding
D-isomers and the amino acid sequence of the peptide is reversed
(cf. Table 1) [16]. As riDOM is composed of D-amino acids, it can be
expected to have a higher resistance to enzymatic degradation, and
thus to show a better in vivo performance [16–18]. riDOMmediates efﬁ-
cient transfection andwhenmixedwith cationic polymeric compounds a
synergistic enhancement of transfection is observed [16]. The net positive
charge of riDOM facilitates the binding to DNA. We have shown by
dynamic light scattering and solid state 31P NMR that riDOM in solution
forms stable nanoparticles, composed of ~250 riDOM molecules, with a
diameter of ~13 nm and a ζ-potential of 22 mV [6]. It binds to anionic
polymers such as DNA or heparan sulfate with a high afﬁnity [6]. During
the binding process the riDOM nanoparticles are dissolved and larger
DNA/riDOM or heparan sulfate complexes are formed. The physical–
Table 1
Chemical structure of riDOM. In red — positively charged amino acids.
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ing peptides or poly-cations [19–25].
Efﬁcient internalization of transfecting agents can be due to insertion
into and perturbation of lipid membranes as shown for cell penetrating
peptides such as transportan and pep-1 [26,27]. Alternatively, the uptake
of cationic molecules can be mediated by anionic glycosaminoglycans
(GAGs), which are present on almost all cell surfaces [24,28–31]. We
were therefore interested to characterize the mechanism of interaction
and the binding afﬁnities of riDOM with lipid membranes as it could
shed light on the transfection mechanism.
We have used high-sensitivity isothermal titration calorimetry
(ITC) to obtain a complete thermodynamic characterization of riDOM
binding to lipid bilayers composed of 1-palmitoyl-2-oleoyl-sn-glycero-
3-phosphatidylcholine (POPC) and 1-palmitoyl-2-oleoyl-sn-glycero-3-
phosphatidylglycerol (POPG). Dynamic light scattering measurements
were used to characterize size and ζ-potential of riDOM/lipid com-
plexes. Structural properties of the peptide alone and upon association
with lipidmembraneswere followedby circular dichroism(CD) spectros-
copy. In addition the structure of the phospholipid bilayer in the presence
of riDOM was studied with solid-state phosphorus-31 nuclear magnetic
resonance spectroscopy (31P NMR) and with a dye efﬂux assay.
2. Materials and methods
2.1. Materials
Syntheticmelittinwas fromBachem (Bubendorf, Switzerland). Retro-
inverso dioleoylmelittin (riDOM) (MW: 3723 Da) was from F. Hoffman-
La Roche Ltd. (Basel, Switzerland). The chemical structure of riDOM
is given in Table 1. 1-Palmitoyl-2-oleoyl-sn-glycero-3-phosphocholine
(POPC) and 1-palmitoyl-2-oleoyl-sn-glycero-3-phospho-glycerol (POPG)
were purchased from Avanti Polar Lipids Inc. (Alabaster, AL). 8-
Aminonaphtalene-1,3,6-trisulfonic acid, disodium salt (ANTS) was from
Molecular Probes (Eugene, Oregon, USA). N,N′-p-xylylenebis(pyridinium
bromide) (DPX) was from Sigma Aldrich (Buchs, Switzerland).
All other chemicals were of analytical or reagent grade. Tris buffer
(10 or 25 mM tris(hydroxymethyl)aminoethane, pH 7.4) was prepared
with 18 MΩwater obtained from a NANOpure A ﬁltration system. NaCl
concentrations were typically 50 mM if not speciﬁed otherwise. The
samples were degassed immediately before use.
2.2. Preparation of lipid vesicles
A deﬁned amount of POPCwas dried from a stock solution in chloro-
form with a gentle stream of nitrogen followed by a high vacuum
overnight. For POPC/POPG mixed membranes, the amount of POPC
was weighed and mixed with a deﬁned volume of POPG stock solution
in chloroform to yield a POPC/POPGmolar ratio of 75/25 (mol/mol). The
solvent was removed as above, and the lipid ﬁlm was exposed to high
vacuum overnight and weighed again. For POPC/POPG/PEG mixtures
the POPC/POPG lipid ﬁlm was mixed with a deﬁned volume of PEG
stock solution in chloroform to yield a POPC/POPG/PEG molar ratio
of 74/25/1 (mol/mol/mol). The solvent was removed and the lipid
weighed again. The lipid ﬁlm was resuspended in buffer and vortexed,leading to multilamellar vesicles (MLVs) with cL0 ~10 mM. Large
unilamellar vesicles (LUVs) with a diameter of d ~100 nm were pre-
pared by extrusion of the MLV suspension. After ﬁve consecutive
freeze–thaw cycles, MLVs were extruded 15 times through a polycar-
bonate membrane with a pore diameter of 100 nm (Whatman, Clifton,
NJ). Small unilamellar vesicles (SUVs) with a diatmeter of 25–30 nm
were prepared by sonication of the MLV suspension using a titanium
tip ultrasonicator (Branson Soniﬁer, Danbury, CT) until an almost clear
solution was obtained (40 min). Metal debris from the sonicator tip
was removed by centrifugation for 4 min in an Eppendorf 5415 C bench-
top centrifuge (Vaudaux-Eppendorf AG, Schonenbuch, Switzerland).
2.3. 31P solid-state NMR
Solid-state 31P NMR experiments were performed on a Bruker
Avance 400 MHz spectrometer (Bruker AXS, Karlsruhe, Germany). 8–
10 mg of POPC/POPG (75/25 mol/mol) were dispersed in 150–500 μL
buffer (25 mMTris, 50 mMNaCl, pH 7.4) containing different amounts
of riDOM. The samples were vortexed, freeze-thawed and vortexed
again. The pure riDOM was measured at a concentration of 8.63 mg
dissolved in 180 μL Tris buffer.
Spectra were recorded at 162 MHz using a pulse-acquire sequence
with broadband proton decoupling (WALTZ-16) and a recycle delay of
5 s. The excitation pulse length was 4.5 μs and 20,000 free induction
decays (FID)were accumulated. In themeasurements of riDOM in the ab-
sence of lipids a recycle delay of 1 s, and an excitation pulse of 4.5 μswere
used and 50,000 FID were accumulated.
The FIDwere exponentiallymultiplied prior to Fourier transformation
corresponding to a 100 Hz line broadening.
2.4. Isothermal titration calorimetry
A MicroCal VP-ITC calorimeter (MicroCal, Northampton, MA) was
used. Lipid–into-peptide titrations were performed by injecting 5–
12 μL aliquots of lipid suspension at cL0 ~10 mM into the calorimeter
cell (Vcell = 1.4037 mL) containing melittin or riDOM, at concentra-
tions of ~10–30 μM. Peptide–into-lipid titrations were performed
by injecting 10 μL aliquots of a peptide solution (criDOM ~200 μM) into
a lipid SUV suspension (concentration ~10 mM).
The heats of dilution were determined in control titrations by
injecting the lipid suspension or the peptide solution into buffer. The
heats of dilution were small and were included in the ﬁnal analysis.
Raw data were processed using the Origin software provided with the
instrument. If not speciﬁed otherwise all measurements were performed
in 25 mM Tris, 50 mM NaCl, pH 7.4.
2.5. Circular dichroism spectroscopy
CD measurements of riDOM were made with and without POPC/
POPG (75/25 mol/mol) small unilamellar vesicles (SUV) in buffer
(25 mM Tris, 50 mM NaF, pH 7.4) with a Chirascan CD spectrometer
(Applied Photophysics Ltd., Leatherhead, U.K.).
A quartz cuvette with a 1 mm path length was used. All spectra
were corrected by subtracting the buffer or buffer with lipid baseline.
The percentage of peptide secondary structure was estimated from a
computer simulation based on the reference spectra obtained by Reed
and Reed [32].
2.6.Measurement of vesicle size and ζ-potential with dynamic light scatter-
ing (DLS)
The size and ζ-potential of riDOM nanoparticles in the absence and
the presence of different amounts of POPC/POPG (75/25 mol/mol) SUVs
were measured with a Zetasizer Nano ZS (Malvern Instrument Ltd.,
Worcestershire, UK). Samples were prepared in Tris buffer (25 mM
Tris, 50 mM NaCl, pH 7.4) and measured at room temperature.
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Fig. 1. Circular dichroism spectra of ri-melittin-SH and riDOM in buffer and with lipid
vesicles. (•••, short dot) ri-mel-SH at a concentration of 19.21 μM in buffer, no lipid;
( , short dash) ri-mel-SH with POPC/POPG (75/25 mol/mol) SUVs cL0 : cp0 = 70;
( , dash-dot line) riDOM in buffer, no lipid; ( , solid line) riDOM at a concentration
of 42 μM with 1.13 mM POPC/POPG (75/25 mol/mol) small unilamellar vesicles,
cL0 : cp0 = 26.9. All measurements in 25 mM Tris, 50 mM NaF, pH 7.2 at 30 °C.
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ANTS/DPX release measurements were performed on a Jasco
FP-6500 Spectroﬂuorometer (Jasco Inc., Easton, MD, USA). A lipid ﬁlm
(POPC or POPC/POPG (75/25 mol/mol)) was prepared as described
above, and Tris buffer containing 12.5 mM ANTS and 45 mM DPX was
added. After ﬁve freeze–thaw cycles, MLVs were extruded 20 times
through a polycarbonate membrane with a pore diameter of 100 nm
(Whatman, Clifton, NJ). Unentrapped dye was removed from the large
unilamellar vesicles (LUVs) by gel ﬁltration on a Sephadex G75 column
equilibrated with Tris buffer.
The dye-containing LUVs were diluted in a 5 mm quartz cuvette to
yield cL0 = 1.75 mM in Tris buffer. riDOM was added by injection of a
stock solution under rapid mixing. The release of dye from vesicles
wasmonitored using an excitation wavelength of 360 nm and an emis-
sion wavelength of 518 nm. The intensity was monitored for 6–7 min.
The intensity value for 100% lysis (maximum leakage) was obtained
by injection of 25 μL of a 5% Triton X-100 solution. The measurements
were performed at different peptide concentrations to produce different
peptide-to-lipid molar ratios.
2.8. Binding model
The analysis of the ITC experiments proceeds in two steps [33].
(i) The injection of phospholipid vesicles into a melittin or riDOM solu-
tion produces a series of heat peaks, hi, which decrease to zero when all
peptide in the calorimeter cell is lipid-bound. The his are used to derive
the binding isotherm, Xb = f(ceq), which describes the molar amount
of bound peptide as a function of the free peptide, ceq. Xb is the extent
of binding, deﬁned by Xb = cb/cL0, where cb is the molar concentration
of bound peptide and cL0 is the total lipid concentration. It is assumed
thatmelittin and riDOMrapidly translocate across the bilayermembrane.
ceq is the equilibrium concentration of free peptide. The concentrations of
free and bound peptide add up to the total protein concentration, cP0.
cb þ ceq ¼ Xbc0L þ ceq ¼ c0P ð1Þ
Xb can be measured directly in the ITC experiment and the binding
isothermXb vs. ceq can be constructedwithout applying a speciﬁc binding
model [33]. (ii) The binding of a cationic peptide to a neutral or charged
membrane is driven by both chemical adsorption (characterized by a
binding constant K0) and electrostatic attraction/repulsion (characterized
by surface potentialψ and surface charge densityσ). A negatively charged
membrane will exert a strong attractive force for a cationic peptide.
However, if the peptide binds beyond electroneutrality (strong chemical
adsorption) the interaction becomes repulsive as the now positive
surface charge of themembranewill repel ions of like charge. For neutral
membranes the binding of the cationic peptide immediately generates an
electrostatic repulsion. The surface concentration of peptide, cM, directly
above the plane of binding is different from its equilibriumconcentration,
ceq, in bulk solution. cM can be calculated for a given surface potential ψ
with the Boltzmann equation.
cM ¼ ceqe−zp F0ψ=RT ð2Þ
where zp is the effective peptide charge, F0 the Faraday constant and RT
the thermal energy. The peptide binding to the lipid membrane can
then be described by a surface partition equilibrium
Xb ¼ K0cM ¼ K0ceqe−zpψF0=RT: ð3Þ
In this model, “binding” is deﬁned as a nonspeciﬁc adsorption of pep-
tide to the lipidmembrane. As peptide is bound to themembrane surface,
it changes the membrane surface charge density, σ, and, in turn, the sur-
face potential. The connection between σ and the surface potential ψ isgiven by the Gouy–Chapman theory [34,35]. We have used this model,
that is, the combination of a surface partition equilibrium with the
Gouy–Chapman theory to successfully describe the interaction ofmelittin
[2,36,37] and other peptides [38–42] with neutral and charged mem-
branes. Themodel demonstrates that the binding constant K0 is indepen-
dent of electrostatic effects and is constant over a large concentration
range. As a further result the analysis yields the effective charge, zp, of
the peptide.
It should also be noted that the model as applied here includes Na+
binding to the phosphoglycerol headgroup by a Langmuir adsorption
isotherm [38]. The Na+ ion binding constant is KNaþ ¼ 0:6M−1.
3. Results
3.1. riDOMconformationwith andwithout lipids as determinedwith circular
dichroism spectroscopy
Fig. 1 compares the CD spectra of retro-inverso [cys1]melittin
(ri-mel-SH; no lipid extension) and riDOM in buffer with and without
lipid vesicles. ri-mel-SH in buffer adopts a random coil conformation
(60–70% random coil). Upon addition of phospholipid vesicles the
conformation changes to ~60% α-helix, a behavior very similar to
that of authentic melittin [3,5]. Compared to melittin, the CD spectra
of ri-mel-SH aremirror-imaged at the x-axis as themolecule is composed
of D-amino acids only. A different CD-spectrum is obtained for riDOM. The
peptide conformation of riDOM in solution is characterized by a large
contribution of β-structure (31% β-structure, 30% α-helix, 39% random
coil) [6]. This structure is almost temperature-independent. In the pres-
ent study POPC/POPG (75/25 mol/mol) vesicles (SUVs) were added to
the riDOM solution. The CD spectrum of riDOM (Fig. 1) was measured
in excess lipid at cL0 : cP0 = 28.5; nevertheless, the spectrum is virtually
identical to that of riDOM without lipid. At this lipid-to-riDOM ratio
a homogeneous lipid bilayer is observed with 31P NMR spectroscopy
(cf. below). riDOM appears to be completely immersed in the lipid
bilayer. Nevertheless, the CD spectrum of riDOM does not display the
high α-helix content observed for ri-mel-SH measured under the same
conditions.
3.2. Size effects and ζ-potential measurements of riDOM–phospholipid
interactions
riDOM is not soluble in monomeric form but aggregates into
nanoparticles of well-deﬁned size (d ~13 ± 1 nm) composed of 220–
971G. Québatte et al. / Biochimica et Biophysica Acta 1838 (2014) 968–977270 molecules [6]. Using dynamic light scattering (DLS) we studied the
interaction of riDOM nanoparticles with small unilamellar vesicles
(SUVs) composed of POPC/POPG (75/25 mol/mol). In the absence of
riDOM, the vesicle diameter was 24.6 nm and the ζ-potential −29 mV
(25 m Tris, 50 mMNaCl, pH 7.4, 30 °C). The calculated Henry correction
factor for 25 nm SUVs was 1.26 [43]. The corrected ζ-potential of the
POPC/POPG SUVs was thus−34.5 mV.
In Fig. 2 the vesicle size and the corresponding ζ-potential are plot-
ted vs. the riDOM-to-lipidmolar ratio. In a ﬁrst experiment, themeasur-
ing cell contained SUVs (POPC/POPG (75/25 mol/mol), cL0 = 0.84 mM)
and riDOM nanoparticles were added. The initial vesicle size of ~25 nm
remained nearly constant up to cP0 : cL0 = 0.016 (Fig. 2A). At these
low riDOM concentrations the nanoparticles were integrated into the
lipid bilayer with little change in the dimensions of the SUVs. Upon
further addition of riDOM the vesicle diameter increased to d ~35 nm
at a cP0 : cL0 = 0.03, with DLS still indicating a monomodal vesicle
distribution. Beyond this threshold the particle size increased rapidly
to a maximum of 65–70 nm (accounting for 70% of total volume) at
cP0 : cL0 = 0.15–0.2. In addition, much larger particles with d ~300 nm
(~30% total volume) were observed.
In a second experiment the sample cell contained the riDOM nano-
particles (diameter 12.2 nm; cP0 = 39.3 μM) and POPC/POPG SUVs
were added. This initially produced large phospholipid–riDOMparticles
with a diameter of d ~73 nm at cP0 : cL0 = 0.16. Upon further addition of
lipid, the size of the particles decreased gradually to reach d ~30 nm at
cP0 : cL0 = 0.02. Fig. 2A displays both experiments and shows a good
agreement between the two modes of titration. It demonstrates that
the riDOM-induced vesicle aggregation is a dynamic equilibrium which
can be reversed at sufﬁciently high riDOM concentrations.
The increase in aggregation size further demonstrates that riDOM
has little or no detergent-like properties. An interesting contrasting
example is the 20-residue tandem dimer (LRKLRKRLLR)2 to which two
palmitoyl chains were linked [44]. This amphipathic molecule is similar
to riDOM as it also carries 2 fatty acyl chains. However, its peptide-0.05 0.00 0.05 0.10 0
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Fig. 2. Binding of riDOM to lipid vesicles. (A) Size measurements with dynamic light scattering
buffer: 25 mMTris, 50 mMNaCl. ( ) Different amounts of a riDOM stock solution (criDOM = 18
experiment. Lipid vesicles (cL0 = 8.38 mM)were added to a riDOM solution (criDOM = 39.3 μM
tion. (B) ζ-Potential measurements. Interaction of riDOMnanoparticles with POPC/POPG (75/25
injected into a riDOM solution. The arrows indicate the direction of the concentration changesextension is highly charged and the molecule dissolves lipid bilayers
already at low concentrations.
Fig. 2B displays the variation of the ζ-potential as a function of the
riDOM-to-lipid ratio. Data of both types of titration (lipid-into-riDOM,
riDOM-into-lipid) are included and again good agreement is observed.
The ζ-potential of the pure lipid vesicles was negative due to its
POPG content. Addition of the cationic riDOM nanoparticles led to an
almost linear increase in the ζ-potential with the increasing cP0 : cL0
ratio. The ζ-potential became zero at cP0 : cL0 ~0.11–0.125. As the POPG
content was 25% of total lipid, the cP0 : cPOPG0 ratio at electroneutrality
(ζ = 0 mV) was ~0.45–0.5, provided all POPG was available to riDOM.
As POPG carries the electric charge z = −1, the average riDOM charge
must be zp ~2–2.2 to produce electroneutrality. The effective riDOM
charge is clearly smaller than the maximum riDOM charge of zp = 5.
This result is however consistent with riDOM binding data to DNA
and heparan sulfate where effective riDOM charges of 1.7 (DNA(bp))
and 1.8 (heparan sulfate) were deduced [6]. It is further in agree-
ment with the more precise ITC data discussed below where zp is in
the range of 1.5 ≤ zp ≤ 2.0 at 30 °C.
3.3. 31P NMR studies of riDOM–phospholipid interactions
The molecular structure of riDOM upon insertion into bilayer
membranes was investigated with 31P NMR. Solid state 31P NMR
spectroscopy is a quantitative technique to study the structure and
dynamics of both lipid model membranes and biological membranes.
Characteristic spectra of different shapes are observed for bilayers, hex-
agonal phases, and micelles [45]. For studies of membranes, 31P NMR
spectroscopy usually requires multilamellar lipid dispersions. Small
vesicles or micellar structures produce sharp lines as rapid vesicle rota-
tion or micellar ﬂuctuations average out the chemical shielding anisot-
ropy of the 31P nucleus. In the present experiments, a lipid ﬁlm was
produced on the surface of a glass tube and a small amount of a concen-
trated riDOM solution was added. The mixture was then vortexed to.15 0.20 0.25 0.30 0.35
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Fig. 3. 31P NMR spectra of multilamellar phospholipid dispersions containing different concentrations of riDOM. Phospholipid composition: POPC/POPG 75/25 (mol/mol). Buffer compo-
sition 25 mMTris, 50 mMNaCl, pH 7.4. 8–10 mg of phospholipidwith different amounts of riDOMwere suspended in 150–200 μL buffer. (A) riDOM/phospholipidmolar ratio r = 0.014.
(B) r = 0.1. (C) r = 0.18. (D) Pure riDOM particles. 8.63 mg riDOM dissolved in 180 μL buffer. riDOM particle diameter ~13 nm as determined by dynamic light scattering.
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phospholipid ratios are displayed in Fig. 3. In Fig. 3A (B) the cP0 : cL0
ratio is 0.014 (0.1). The 31PNMR spectra in Fig. 3A, B are typical for a ran-
domdistribution of bilayer domains (“powder-type spectrum”) and can
be simulated by very similar parameters, that is, a chemical shielding
anisotropy of Δσ = −37 to−39 ppm and an intrinsic line broadening
of 3.5–4 ppm. This result is quite unexpected as the bilayers are com-
posed of three different components, namely 2 phospholipids (POPC,
POPG) and a lipopeptide (riDOM), the latter also containing a 31P-
atom. In the POPC–POPG–riDOM membrane the differences between
the individual molecules are however smoothed out and even the
non-bilayer spectrum of pure riDOM nanoparticles (Fig. 3D) is trans-
formed into a bilayer spectrum. Without knowledge of the chemical
composition, the 31P NMR spectra in Fig. 3A, B of the riDOM-
containing preparations could be mistaken for one-component phos-
pholipid bilayers. The 31P NMR spectra thus provide evidence that the
riDOMnanoparticles are dissolved in the phospholipid bilayer. It should
be noted that the incorporation of riDOM leaves the peptide secondary
structure unchanged but increases the permeability of the lipid mem-
brane (cf. below).
Increasing the cP0 : cL0 ratio to 0.18 led to the 31P NMR spectrum
shown in Fig. 3C. It can be simulated by a superposition of a bilayer
spectrum with a chemical shielding anisotropy of Δσ = −39 ppm
and the spectrum of pure riDOM nanoparticles with an isotropic line
width of −4 ppm (Fig. 3D). At sufﬁciently high riDOM concentrations
not all riDOM nanoparticles are dissolved but some fraction is incorpo-
rated in intact form into the phospholipid bilayer.
3.4. Efﬂux measurements
Large unilamellar vesicles (~100 nm diameter) were prepared in
buffer (25 mM Tris, 50 mM NaCl, pH 7.4) in the presence of 12.5 mM
ANTS/45 mM DPX. External dye was removed by gel ﬁltration over
Sephadex. The lipid concentration was typically 1.75 mM. riDOM was
added at different concentrations and the dye efﬂux was measuredas a function of time. After 6 min, maximum dye release, F∞, was
established by dissolving the vesicles with Triton X-100. Fig. 4A shows
the outﬂow of dye measured by the increase in ﬂuorescence for several
riDOM concentrations. Increasing the riDOM concentration increases
both the extent and the speed of dye release. The data in Fig. 4A can
be normalized to yield the fraction F(t) of dye retained in the LUVs:
F tð Þ ¼ F∞−F tð Þ
F∞−F0
: ð4Þ
F(t) is the experimental ﬂuorescence intensity at time t, and F∞ the
ﬂuorescence intensity after vesicles disruption. F0 is the background
ﬂuorescence at the beginning of the experiment. The normalized efﬂux
curves calculated from the data in Fig. 4A are displayed in Fig. 4B. They
can be described quantitatively by a 2-exponential decay of the form
f tð Þ ¼ A0 þ A1  e−t=τ1 þ A2e−t=τ2 ð5Þ
The amplitudes A0, A1 and A2 denote the fraction of lipid vesicles
which show either no dye release (A0) or dye release (A1, A2), the latter
with time constants τ1 or τ2, respectively. The ﬁt parameters for POPC
and POPC/POPG (75/25 mol/mol) LUVs are summarized in Table 2.
Inspection of Table 2 reveals a systematic variation of all parameters
with the riDOM:lipid molar ratio. At cP0 : cL0 ≤0.006 a large fraction of
vesicles showed no efﬂux at all. The population of non-leaking vesicles
(A0) decreased linearly with increasing riDOM concentration and was
replaced by two vesicle populations with long (τ1 ~300–120 s) and
short (τ2 ~40–4 s) relaxation times. Fig. 4C shows that for POPC/POPG
(POPC) LUVs the leakage was 100% at cP0 : cL0 N0.02 (0.01) and that
POPC/POPG LUVs are more tightly sealed than POPC LUVs. Increasing
the riDOM concentration not only increases the fraction of dye-
permeable vesicles but also decreases the relaxation times (cf. Table 2).
At the highest riDOM-to-lipid ratio cP0 : cL0 = 0.06 the dye efﬂux can be
described by a single exponential with a short (~4 s) relaxation time.
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Fig. 4.Dye efﬂux from lipid vesicles induced by riDOM. Increasing concentrations of riDOM
were added to POPC/POPG (75/25 mol/mol) large unilamellar vesicles (LUVs). The LUVs
were loaded with the ﬂuorophore-quencher pair 12.5 mM ANTS/45 mM DPX in buffer
(25 mM Tris, 50 mM NaCl, pH 7.4). The lipid concentration was 1.75 mM. (A) Efﬂux
curve, ﬂuorescence intensity F(t) versus time. riDOM/lipid ratios from bottom-to-top are
0.001, 0.006, 0.01, and 0.06 (2 experiments). (B) Dye retained in LUVs according to
(F∞ − F(t)) / (F∞ − F0). Color code as in (A). (C) Fraction of non-leaking lipid vesicles. A0
is the normalized amplitude of lipid vesicles which in the bi-exponential analysis do not
show dye leakage. ( ) POPC/POPG (75/25 mol/mol) LUVs; ( ) POPC LUVs. Mixed POPC/
POPG LUVs are less sensitive to riDOM induced dye efﬂux than POPC LUVs.
Table 2
Dye efﬂux data analyzed according to f(t) = A0 + A1e−t/τ1 + A2e−t/τ2.
Lipid riDOM/Lipid A0 A1 τ1 (s) A2 τ2 (s)
POPC 0.001 0.83 0.17 296 ± 3 – –
0.006 0.22 0.50 174 ± 3 0.29 38
0.01 0.09 0.36 114 0.55 25
0.06 0.02 ± 0.02 – – 0.95 ± 0.05 3.8 ± 0.3
POPC/POPG
75/25
mol/mol
0.001 0.94 0.03 137 0.03 9.6
0.006 0.7 0.13 120 0.11 8.2
0.01 0.53 0.18 135 0.26 9.0
0.06 – – – 1.0 4.3 ± 1.5
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measured with isothermal titration calorimetry (ITC)
The riDOM–phospholipid thermodynamics was investigated with
ITC. Experimentswere performed as a function of temperature and phos-
pholipid compositionwith POPC and POPC/POPG (75/25 mol/mol) SUVs.
The size of the vesicles was measured with dynamic light scattering.
Fig. 5 shows a typical titration experiment at 10 °C. The calorimeter
cell (Vcell = 1.4037 mL) contained riDOM (30.8 μM) in buffer. Each
heat ﬂow peak in Fig. 5A corresponds to the injection of 10 μL POPC
SUVs at a phospholipid concentration of cL0 = 8.0 mM, producing anexothermic response, hi. The reaction comes to an end when all riDOM
is bound to the injected lipid. The molar heat of reaction is then given
by∑hi/(cp0 ⋅ Vcell) where cP0 is the riDOM concentration in the calorime-
ter cell. For the example given in Fig. 5 the reaction enthalpy is ΔH-
riDOM
0 =−6.0 kcal/mol (at 10 °C).
Fig. 6A summarizes the temperature dependence of ΔHriDOM0 for the
various systems investigated. The reaction enthalpies were always
small and exothermic and became less negative with increasing tem-
perature. Themolar heat capacity change as referred to riDOMwas pos-
itive with ΔCP0 = 262 cal/molK for POPC SUVs and 90 cal/molK for
POPC/POPG SUVs. Also included in Fig. 6A are the enthalpies measured
for authentic melittin binding to POPC/POPG SUVs. The solid line is the
linear regression analysis of the latter experiments yielding a slope of
ΔCP0 = 298 cal/molK. The positive heat capacity changes in all three
experiments are quite unexpected as hydrophobic interactions are char-
acterized by a negative ΔCP0. Indeed, melittin binding to 100 nm vesicles
(LUVs) of the same composition led to ΔCP0 = −200 to−400 cal/molK
[2]. We have therefore measured the binding enthalpy of riDOM to
POPC/POPG LUVs by titration of riDOM into a LUV suspension. In the
temperature interval 20–40 °C the molar heat capacity change is also
negative with ΔCP0 = −85 cal/molK.
The variation of the heats of reaction, hi, can be used to deduce the
binding isotherm. Fig. 5B shows the analysis of the experimental data
in Fig. 5A in terms of the surface partition model (solid line). The bind-
ing constant for the data shown in Fig. 5 was K0 = 8 × 104 M−1. Fig. 6B
then displays the temperature dependence of the binding constant, K0,
for POPC and POPC/POPG (75/25 mol/mol) SUVs. The error in evaluat-
ing K0 is mainly caused by the small reaction enthalpies, ΔHriDOM0 . Also
included in Fig. 6B are the binding constants of authentic melittin
recorded for POPC/POPG (75/25 mol/mol) SUVs. Despite the missing
lipid extension they are similar to those of riDOM and fall in the range
of 3 × 104 M−1 to 6 × 104 M−1 for temperatures between 50 °C and
10 °C. We have previously determined the binding constant of melittin
to POPC/POPG SUVswith CD spectroscopy [37]. The binding constant K0
was (4.5 ± 0.6) × 104 M−1 in agreement with the analysis presented
here. A numerical summary of all thermodynamic data is presented in
Table 3.
The solid line in Fig. 6B represents the theoretical temperature
dependence of melittin binding to POPC/POPG SUVs calculated with the
van't Hoff equation and the temperature dependent enthalpy in Fig. 6A
(linear regression ΔHmel0 (kcal/mol) = 0.298x − 11.59; x = in °C). The
binding afﬁnity exhibits aminimum at 38 °C as the reaction enthalpy be-
comes zero. Fig. 6B shows close numerical agreement between the bind-
ing constants K0 of authentic melittin and riDOM, independent of the
lipid composition.
Inspection of Table 3 shows that the effective riDOM charge, leading
to a consistent evaluation of all binding curves, is independent of the
lipid composition. Its average value zriDOM = 1.63 ± 0.27 is clearly
below the nominal charge of ri-melittin of z = +5 but in agreement
with the ζ-potential measurements and previous studies with DNA
and heparan sulfate [6]. The effective charge of authentic melittin in
the present analysis is however larger with zmel = 4, in agreement
with an earlier study with POPC/POPG LUVs [2].
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Fig. 5. Isothermal titration calorimetry. Interaction of riDOM with POPC unilamellar vesicles. A riDOM solution (30.8 μM) was titrated with POPC SUVs (8 mM) in buffer (25 mM Tris,
50 mM NaCl, pH 7.4) at 10 °C. (A) Heat ﬂow. Injection of 10 μL aliquots (cL0 = 8 mM). (B) Heats of reaction, hi. ( ) Experimental data obtained by integration of heat ﬂow. Solid line:
membrane partition model combined with electrostatic repulsion calculated with the Gouy–Chapman theory. Effective charge of riDOM z = 1.6; partition constant K0 = 8 × 104 M−1,
partition enthalpy ΔHriDOM = −6.0 kcal. It was assumed that riDOM can translocate rapidly across the membrane.
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riDOM is an efﬁcient transfection agent, melittin however is not.
Speciﬁc toxicological effects aside, the physical―chemical results
obtained here provide insight into the different action mechanisms of
the two molecules.
The interaction of authentic melittin with lipid membranes has been
studied extensivelywith differentmethods. ITC data have been publishedB
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Fig. 6. Thermodynamic parameters for the binding of riDOM and authentic melittin to bilayer m
(▲) riDOM binding to POPC/POPG (75/25 mol/mol) SUVs. ( ) riDOM binding to POPC SUVs.
melittin. It was calculated with the van't Hoff equation using the enthalpy data of (A).for 100 nm vesicles (LUVs) [2] but not for 30 nm vesicles (SUVs). ITC
measurements on melittin binding to SUVs are therefore included as a
control in the present study.
4.1. riDOM nanoparticles with and without phospholipids
Authentic melittin in solution is mainly random coil at low μM con-
centrations. It forms α-helical tetramers at concentrations ≥100 μM30 40 50
perature (°C)
30 40 50
embranes. (A) Binding enthalpy ΔH0. (B) Binding constant K0. (♦) Authentic melittin and
The solid line in (B) corresponds to the theoretical temperature dependence of authentic
Table 3
Thermodynamic parameters. Binding of riDOM and melittin to POPC/POPG (75/25 mol/mol) bilayers.a
Peptide Lipid Temp
°C
zriDOM ΔHriDOM
kcal/mol
K0
M−1
riDOM POPC SUVs 10 1.6 ± 0.1 −6.0 ± 0.1 (7.0 ± 1.2) × 104
20 1.00 −2.8 ± 0.1 (3.2 ± 0.5) × 104
30 1.6 ± 0.3 −0.76 5.0 × 104
POPC–POPG SUVs 75/25 mol/mol 10b 1.9 ± 0.3 −5.9 ± 0.5 (5.5 ± 0.6) × 105
10 1.9 ± 0.3 −6.7 ± 0.6 (6.5 ± 0.2) × 104
20 1.60 −6.1 ± 0.5 (5.2 ± 2.0) × 104
30 1.50 −4.5 ± 0.3 8 × 104
Melittin POPC–POPG SUVs 75/25 mol/mol 10 4 −9.2 6.0 × 104
20 4 −5.3 4.0 × 104
30 4 −2.15 3.3 × 104
40 4 0.7 3.1 × 104
50 4 2.7 3.4 × 104
a If not otherwise stated all measurements in 25 mM Tris, 50 mM NaCl, pH 7.4.
b 25 mM Tris, 25 mM NaCl, pH 7.4.
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conformation [5]. The membrane-bound melittin also tends to form
aggregates which have been characterized by isothermal titration calo-
rimetry and spectroscopic methods [2,4]. The melittin aggregates com-
prise 6–20 monomers with a low stability constant of ~20–40 M−1 [2].
The lipopeptide riDOM shows a different behavior as it forms stable
nanoparticles in solution with a 31P NMR spectrum typical for isotropic
tumbling of a large particle [6]. The secondary structure of ri-mel-SH
without lipid extension is 73% random coil in buffer, changing to 60%
α-helix upon addition of phospholipid SUVs. The β-sheet content of
ri-mel-SH is only 17% in buffer and 8% in the bilayer membrane. In con-
trast, riDOMshows almost equal contributions ofα-helix (30%),β-sheet
(31%) and random coil (39%). The addition of lipid induces only small
changes in the riDOM secondary structure (α-helix 30%, β-sheet 35%,
and random coil 35%).
We can use the secondary structure for a rough estimate of the riDOM
length. Using0.15 nm for anα-helical segment and0.35 nm for aβ-sheet
segment we calculate the riDOM (i) α-helix in buffer (lipid) as ~1.0 nm
(1.2 nm), (ii) β-sheet in buffer (lipid) as 3.5 nm (3.0 nm), (iii) lipid moi-
etywhen linearly extended as ~3.5 nm and (iv) linker region as ~0.8 nm.
For a spherical particlewith a diameter of 13.4 nm the length of an in-
dividual riDOMmolecule cannot exceed 6.7 nm. Based on hydrophobici-
ty considerations, the lipid moiety of riDOMmust form the inner core of
the spherewhile the polar N-terminus (amino acids qqkrkr of ri-mel-SH)
(cf. Table 1) is exposed to the aqueous phase. With some ﬂexing motion
of the lipid chains, the lipid moiety contributes ~2.9 nm to the particle
radius. This leaves 3.8 nm as the maximum extension for peptide and
linker moiety, which is clearly less than the estimated 5.3 nm for a lin-
ear alignment of α-helix, β-sheet and linker segments. Some folded
conformation of the peptide moiety is therefore required to adjust to
the space requirements in the nanoparticle. Upon addition of phospho-
lipid membranes, the CD spectrum and hence the secondary structure
of riDOM are essentially unchanged. In contrast, the 31P NMR spectrum
of riDOM changes from that of a slowly tumbling particle to a typical
bilayer spectrum. This suggests that upon insertion into a bilayer mem-
brane the spherical particle is ﬂattened into a disk-like structure of
about the thickness of the bilayer. The ri-melittin residues could form
the inner core of the disk retaining their secondary structure through
peptide–peptide interactions. This model explains (i) the intact bilayer
structure as recorded by 31P NMR and (ii) the simultaneous leakiness of
the bilayer membrane as observed by dye efﬂux.
4.2. Efﬂux measurements
The action mechanism of many antibacterial peptides is based on
their binding to the cell membrane and inducing membrane leakiness.
Quantitative studies on the melittin-induced leakage of lipid vesicles
have been performed by measuring the efﬂux of a self-quenching dye[49]. A graded dye efﬂux was observed as characterized by two distinct
relaxation steps with relaxation times of ~20 s and ~200 s which were
assigned to pore formation. The pore formation rate itself increased in
proportion to the amount ofmembrane-boundmelittin. Efﬂux occurred
already in cases where 0.1–1% of the vesicle surface was covered with
peptide. The number of melittin molecules forming a pore was estimat-
ed as low as 2–4.
Itwas also realized at the same time that the observed dye efﬂuxwas
too slow if a stable pore was formed. Assuming a lipid vesicle with a
diameter of 100 nm and a stable pore with a diameter of 4 nm the dye
efﬂux should have been ﬁnished in a few milliseconds [50]. The rate
determining step thus appeared not to be the efﬂux proper but the
formation of the pore i.e. the association of several melittin molecules
in the correct lateral position.
The dye efﬂux curves observed in this study also suggest the forma-
tion of transient pores through the association of several riDOM mole-
cules. At low cP0 : cL0 ratios, pore formation is rare and many vesicles
show no efﬂux at all. At higher concentrations, riDOM association leads
to two types of pores, characterized by slow and fast relaxation times,
respectively. The contribution of the fast process increases with riDOM
concentration. The concentration dependence of the efﬂux curves re-
quires a dissociation of riDOM nanoparticles in the bilayer membrane.
The variation of the dye efﬂux relaxation times indicates the association
of freely diffusing riDOM molecules into transient pores. Formation of
long-lived, stable pores can be excluded as even theminimum relaxation
time of ~2 s is still 2–3 orders of magnitude longer than the predicted
efﬂux time of a stable pore.
A comparison with authentic melittin allows the following conclu-
sions. (i) The riDOM induced membrane permeability is much reduced
compared to melittin. A large fraction of vesicles remains sealed if
riDOM is employed at low concentration. In transfection studies the
concentration of free riDOM is so small that an injury of the cell mem-
brane by inducing leakage can be excluded. (ii) Pore formation in the
lipid model membrane requires a threshold concentration of riDOM.
Two different types of pores appear to be formed, characterized by
two relaxation times. This behavior is similar to authentic melittin but
the relaxation times of riDOM are shorter than those of melittin. The
lipid anchor of riDOM may force the covalently bound peptide into a
membrane alignment more favorable for peptide–peptide association.
4.3. Thermodynamics of riDOM–membrane interaction
The binding of cationic riDOMormelittin to anionicmembranes is ini-
tiated by the electrostatic attraction to the membrane surface, followed
by chemical adsorption. The binding constant K0 as derived with the
model discussed above refers to the chemical adsorption step only. As
the binding model eliminates electrostatic effects, K0 should be identical
for charged and non-charged membranes provided the membrane
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ly comparing POPC and POPC/POPG SUVs (Table 3). The K0 values of both
membrane compositions are similar and range between 3 × 104 M−1
and 8 × 104 M−1.
The free energy of binding can be calculated as ΔG0 = −RT ln
(55.5 K0) and is in the range of−8.4 to−9.0 kcal/mol. The factor 55.5
is the molar concentration of water. As the concentration of riDOM in
the membrane phase is given as mole fraction, the factor 55.5 converts
the concentration in the aqueous phase to mole fraction as well.
riDOM partitioning into lipid bilayers may be compared with that of
free fatty acids. The partition coefﬁcient and the free energy of transfer
of long-chain fatty acids from water to bilayer membranes have been
measured [51,52]. For oleic acid a partition coefﬁcient of 5 × 105 and a
free energy change of −10.0 kcal have been reported. The partition
coefﬁcient was almost temperature independent.
For 1,2-dioleoyl-sn-glycero-3-phosphoethanolamine (DOPE) with 2
oleic acyl chains a free energy change twice as large (−20 kcal/mol) can
be calculated for the transfer fromwater to the lipidmembrane. Indeed,
DOPE is virtually insoluble in water. However, the riDOM transfer free
energy is only −8 to −10 kcal/mol. The hydrophobic surface area of
DOPE thus appears to be divided into a DOPE–peptide interaction
(50–60%) and a DOPE–bilayer interaction. The former exists already in
the riDOM nanoparticles and is not changed upon insertion into the
membrane as judged from the constancy of the CD spectra. The remain-
ing hydrophobic area is equivalent to about 1 oleic acyl chain.
The binding constants, K0, for authenticmelittin are also in the range
of 3 × 104 M−1 to 6 × 104 M−1 for SUVs (this work) and LUVs [2] and
are thus similar to those of riDOM. The molecular origin of the free en-
ergy of insertion is however completely different. For melittin α-helix
formation and α-helix insertion into the membrane are the driving
forces. It has been estimated that α-helix formation accounts for at
least 50% of the free energy of melittin membrane binding [2].
In spite of their similar binding constants K0, authentic melittin and
riDOMdisplay large quantitative differences in their extent of binding to
negatively charged membrane. This can be traced back to the different
electric charges of the two molecules. Melittin with its effective charge
z = 4 experiences amuch stronger electrostatic attraction to the anion-
ic POPC/POPG membrane than riDOM with z = 1.6–2.0. At identical
melittin and riDOM concentrations in solution this generates a 20–40
times higher surface concentration of melittin compared to riDOM,
generating a correspondingly higher insertion ofmelittin into themem-
brane. This potentiates the melittin-induced leakiness of membranes as
the higher melittin concentration increases pore formation.
Inspection of Fig. 6 and Table 3 demonstrates that the reaction en-
thalpies of riDOM and melittin, ΔH0, are close to zero at physiological
temperatures. As the free energy is ΔG0 ≈ −8 to −10 kcal/mol the
membrane partition of riDOM and authentic melittin is determined
exclusively by entropic contributions. riDOM undergoes no structural
change upon insertion into the membrane and the structure of the
lipid membrane is also unaffected. The molecular origin of the gain in
entropy is therefore a release of hydration water as riDOM inserts into
the membrane.
4.4. riDOM binding to DNA and heparan sulfate
The binding afﬁnities of riDOM and melittin to lipid bilayers must
be compared with those observed for DNA and sulfated glycosamino-
glycans such as heparan sulfate (HS) [6]. riDOM is the vehicle to trans-
port DNA across the cell membrane. HSmay however interfere because
riDOM could stick to sulfated glycosaminoglycans on the outer mem-
brane surface. The microscopic binding constants of riDOM are
5 × 107 M−1 for DNA and 5 × 106 M−1 for HS. Even though lipid is
much in excess, the riDOM:DNA complex will remain intact because
of its high stability. This is further enhanced by the insolubility of DNA
in a hydrophobic environment. As a working model it may be assumed
that the riDOM:DNA complex translocates not as a single species butthat several riDOM:DNA molecules aggregate into a pore with an
inner riDOM–DNA core and an outer lipid mantle, the latter provided
by the lipid extension of riDOM. The HS molecule can compete with
the riDOM:DNA complex because of its large binding constant. An efﬁ-
cient transfection is thus achieved only if riDOM is applied at concentra-
tions above the stoichiometric DNA:riDOM ratio in order to neutralize
the sulfated glycosaminoglycans on the cell surface.
The packing density of the riDOM:DNA complex is also an important
factor in membrane insertion and translocation. For riDOM the packing
density is 1 riDOM:0.85 DNA(bp) and 1 riDOM:1 HS disaccharide unit
whereas for melittin the ratios are less favorable with 1 mel:2 DNA(bp)
and 1 mel:3 HS disaccharide units. The shielding of DNA by riDOM is
distinctly more efﬁcient than the shielding produced by melittin.
5. Conclusions
riDOM is an efﬁcient transfection agent because it is well soluble in
water but nevertheless binds with high afﬁnity to DNA and lipid mem-
branes. Pore formation and riDOM-induced membrane leakiness is
much reduced compared to authentic melittin. The secondary structure
of the riDOM peptide is not changed when riDOM is transferred from
water to the membrane. In contrast, the change in the 31P NMR spec-
trum demonstrates that riDOM via its DOPE extension becomes an
integral part of the bilayer membrane. The free energy of insertion is
however only half of the expected value for DOPE as part of the hydro-
phobic DOPE surface is involved in peptide interaction.
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